(Q65394643)
Statements
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo And Active Comparator Controlled, Dose Escalation Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Escalating Doses Of Pf-05251749 In Healthy Adult And Elderly Subjects (English)
0 references
28 March 2016
0 references
12 January 2017
0 references
97
0 references
18 year
0 references
85 year
0 references